soul trial oral semaglutide cardiovascular outcomes trial (NEJM 2025): led to a 14% ↓ in major CV events vs placebo in T2DM with ASCVD or CKD — no ↑ in serious AEs. #Semaglutide #CardioDiabetes #updatesinmedicine SOUL trial shows oral semaglutide

Verify with your account administrator before purchasing, as some plans require prior documentation of medical necessity or provider authorization

Inflammation of the bursa or mechanical impingement of soft tissues during overhead movement

Researchers will want to ensure that test subjects take it on an empty stomach at least two hours after eating

Many patients stop too soon without guidance, missing simple solutions like dose changes or diet tweaks that could make the process easier

But her first go-around with the medication didnt quite stick

FDA accepted Lantheus' new piflufolastat F-18 formulation, a step in the right direction to lift batch sizes and broaden PSMA-PET access